Work

Preclinical therapeutic synergy of MEK1/2 and IGF1R inhibition in RAS-driven rhabdomyosarcoma

Year: 2020

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(20)31204-1

Authors: M. Yohe, X. Wan, J. Roth, K. Isanogle, C. Robinson, X. Liu, J. Chen, M. Hall, S. Difilippantonio, J. Khan

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, National Center for Advancing Translational Sciences

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3096571331

FWCI:

Cites:

Cited by:

Related to: 10